PROTO SCRIPT PHARMACEUTICAL CORP Net Cash Provided by (Used in) Operating Activities, Continuing Operations
PROTO SCRIPT PHARMACEUTICAL CORP reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$343.98 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2018-03-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2018-03-08
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-09-30 was -$24.30K.
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-06-30 was -$104.70K, a 882.25% decline year-over-year.
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was -$214.98K, a 865.56% decline year-over-year.
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-12-31 was $40.88K.
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was $44.10K, a 15.84% increase from fiscal 2015.
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was $38.07K.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$24.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-08 | -$129.00K derived: sum of 2 quarters · filed 2018-03-08 | -$343.98K 10-Q · filed 2018-03-08 | -$303.10K derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-06-30 | -$104.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-17 | -$319.67K 10-Q · filed 2018-01-17 | -$278.79K derived: sum of 3 quarters · filed 2018-01-17 | -$317.03K derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-03-31 | -$214.98K 10-Q · filed 2017-11-22 | -$174.10K derived: sum of 2 quarters · filed 2017-11-22 | -$212.34K derived: sum of 3 quarters · filed 2018-03-08 | -$198.95K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-12-31 | $40.88K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-10-19 | $2.64K derived: sum of 2 quarters · filed 2018-03-08 | $16.02K derived: sum of 3 quarters · filed 2018-03-08 | $44.10K 10-K/A · filed 2017-10-19 |
| 2016-09-30 | -$38.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-08 | -$24.86K derived: sum of 2 quarters · filed 2018-03-08 | $3.22K 10-Q · filed 2018-03-08 | |
| 2016-06-30 | $13.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-17 | $41.47K 10-Q · filed 2018-01-17 | ||
| 2016-03-31 | $28.08K 10-Q · filed 2017-11-22 | |||
| 2015-12-31 | $38.07K 10-K/A · filed 2017-10-19 |